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Abstract  
It is well-established that drugs could be leading cause of occurrence of numerous diseases, including 
pemphigus, being either inducer or triggering factor of the autoimmunity. Despite medications, it should be kept in 
mind that chronic or acute infections are also capable of being a trigger in various types of cutaneous eruptions, 
including pemphigus. The rapidly obtained and uncompleted history for accompanied medication leads to general 
mistakes in the subsequent treatment approach, as the first step in such cases is discontinuation of the drug-
inductor. The absence of this information guaranties the fail of the treatment. On the other hand, the lack of 
performed screening for chronic or acute hepatitis and tuberculosis is not the only mistake, regarding the high 
dosage of immunosuppressors that have been planned as regiment and the possible fatal effect on the infection’s 
spread or exacerbation, but also because of the possible triggering ability of chronic or acute infection, which may 
play also a key role in the generation of antigen- or molecular- mimicry, as a potential source of antibodies 
reactive with various tissue antigens. It turns out that although the diagnosis of pemphigus in regular cases is 
usually not a challenge, the treatment occasionally could be, just because of a simple pitfall in anamnesis and 
screening, as in the presented case. Herein, we present a case of a patient with seborrheic pemphigus, which is 
strongly demonstrative for these statements, as we want to emphasise the importance of the first and the most 
powerful clinician’s weapons – the patient’s history and thorough examination. 
 
 
 
 
 
 
 
 
Introduction 
 
Pemphigus is a part from the large group of 
autoimmune bullous diseases with variable clinical 
manifestation, but common histological and 
immunofluorescence characteristics, causing blisters 
and erosions both on the skin and mucous 
membranes, as a result from autoimmunity to 
desmosomal cadherins [1]. Pemphigus is divided into 
two groups, based on the level of acantholysis in the 
epidermis - pemphigus vulgaris (histologically 
presented with suprabasal acantholysis) and 
superficial pemphigus [1][2]. The superficial 
acantholysis could be seen in pemphigus foliaceus 
and its milder subtype - pemphigus seborrheicus (PS), 
which is limited only to seborrheic areas [3]. The other 
superficial variant is pemphigus erythematosus, also 
known as Senear - Usher syndrome, which is 
characterized by immunologic markers both for 
pemphigus foliaceus and lupus erythematosus, but 
uncommon mucous membrane involvement [2][3].  
Although both genetic and exogenous, stress-
related factors have been implicated in the 
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etiopathogenesis of pemphigus in general; antigenic 
triggering is not yet fully understood [4]. However, it is 
well-established that drugs could be leading cause of 
occurrence of the disease, being either inducer or 
triggering factor [4]. The thorough medical history for 
accompanying medication is an essential prerequisite 
for the successful clinical management of pemphigus 
of any type, as the lack of improvement is often 
related to simply pit falls in anamnesis, which is 
unacceptable at the current stage of scientific 
knowledge. Despite medications, it should be kept in 
mind that chronic or acute infections are also capable 
of being a trigger in various types of cutaneous 
eruptions, including pemphigus [5].  
Herein, we present a case, which is strongly 
demonstrative for these statements, as we want to 
emphasise the importance of the first and one of the 
most powerful clinician’s weapons - the patient’s 
history, as well as the mandatory screening for 
infections, prior the introduction of high dosage 
immunosuppressors.  
 
 
Case report 
 
A 67 - year - old Caucasian female patient 
presented with one - year history of spontaneous 
occurrence of painful erosions on the skin and nasal 
mucosa. The patient had been diagnosed with 
seborrheic pemphigus. Seven months prior the 
current hospitalisation, histologically and 
immunofluorescently verified and treated in another 
University dermatological department. The presented 
medical history reported systemic administration of 
methylprednisolone x 40 mg i.m/daily, azathioprine 50 
mg – 2 x 1 table/daily for one month. The current 
hospitalisation in a medical institute of MVR - Sofia, 
Department of Dermatology, Venereology and 
Dermatologic surgery, was because of the lack of any 
improvement of the conducted treatment and 
occurrence of new cutaneous lesions in contrast. The 
clinical examination revealed multiple blisters and 
erosions, partially covered with yellow - brownish 
crusts, disseminated on the seborrheic areas on the 
sun-exposed zone of the décolletage, presternal, 
interscapular and paravertebral spaces (Fig.1 a, b). 
Same lesions were observed on the scalp, while 
superficial erosions were affected the nasal mucosa 
and paranasal skin (Fig. 1 c, d). The thorough medical 
history revealed systemic administration of captopril 
25 mg, because of mild arterial hypertension with 
long-lasting duration. The whole serological screening 
for HBsAg, Anti Hbs, HIV and quantiferon tests was 
performed. The revealed titer of antinuclear antibodies 
(ANA) was 1:100, anti HCV - negative, HIV - negative, 
quantiferon test - negative, but the anti HBcore total 
test - positive. 
 
Figure 1: a, b, c, d - Clinical manifestation of a drug-induced 
pemphigus seborrhoicus, a year after the initial diagnosis 
 
The patient was referred for evaluation of 
virus load in peripheral blood, to differentiate between 
chronic and acute infection, as a possible trigger for 
antigen/ molecular mimicry, which would require 
adequate therapy, as no such examinations, not 
therapy had been introduced to that point. The rest of 
the results from the conducted laboratory blood tests 
were within the normal range. The histological 
examination after biopsy demonstrated 
pseudoepitheliomatous, hyper- and parakeratosis in 
the epidermis with mononuclear perivascular 
infiltration in the dermis. The immunofluorescent 
examination confirmed the diagnosis pemphigus, with 
intercellular deposition of IgG and C3 in the epidermis. 
Diagnose of drug-induced seborrheic pemphigus was 
made, based on the clinical and laboratory findings. 
The administration of captopril was switched to 
valsartan 80 mg. 
Systemic administration of methylpred-
nisolone in a daily dose of 1mg/kg with subsequent 
reduction and azathioprine 2x50 mg daily was 
planned as a therapeutic regiment, in case of 
obtaining negative results from the virus load. 
Meanwhile, the patient was treated with topical 
application of clobetasone proprionate 0.05% and oral 
antihistamines.  
 
 
Discussion 
 
Since the first reported case of drug-induced 
pemphigus by penicillamine in 1969 [6], and captopril 
in 1980 [7], numerous types of drugs have been 
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implicated in the etiopathogenesis of pemphigus, 
either as triggers, or exacerbates of the disease, 
including phenytoin and carbamazepine [4, 8]. Wolf R. 
et al. suggest back in 1991 that clinical course and 
behavior of the disease depends mainly on the type of 
the drug, as the authors first report pemphigus-
induced by drugs containing a sulfhydryl radical (as 
penicillamine) showed spontaneous recovery in up to 
52.6%, after the drug discontinuation, in contrast to 
only 15% spontaneous recovery in pemphigus-
induced by other drugs [6]. Since then, it is known that 
drugs with sulfhydryl radicals induce pemphigus, while 
drugs without sulfhydryl radicals trigger the 
occurrence of the disease in predisposed individuals, 
as the mechanism of drug-induced pemphigus is 
related mainly to drug’s potential to induce 
acantholysis [8][9].  
Despite penicillamine, it is well-established 
that antihypertensive drugs, namely ACE - inhibitors 
can trigger pemphigus or induce exacerbation, 
resembling the mode of action of b - blockers in 
worsening of psoriasis, gold - provoking lichen ruber 
planus, estrogens - lupus, etc. [8]. The drug may act 
either as the main etiological factor for occurrences of 
otherwise mild and therapeutic responsible with drug 
discontinuation or as a triggering factor, resulting in 
idiopathic pemphigus, which is usually more 
therapeutic - resistant, even after discontinuation of 
the drug [10]. The investigated autoimmune response 
is similar in drug-related and non-drug induced 
disease; both showing have tissue - bound and serum 
autoantibodies to DSG1 and/or DSG3, suggesting a 
similar underlying molecular mechanism [11]. While 
the clinical and histological findings in ordinary 
pemphigus and the drug-induced one are quite similar 
and they do not allow such differentiation, the clinician 
should obtain a very thorough medical history, to 
avoid deterioration of the disease, in contrast to 
otherwise correct therapeutic behaviour [8]. However, 
despite the current state of scientific knowledge, and 
the lower incidence of drug-induced seborrheic 
pemphigus recently, inadequate diagnostic and 
therapeutic behavior could be still seen not only 
among hypertension specialists, but also among 
dermatologist, who are obviously not aware that 
severe pemphigus, which is therapeutically resistant 
and aggressive in its clinical behavior, may be caused 
by drugs or triggered by infections also [5][8].  
Despite drugs, various bacterial, viral and 
parasitic agents can activate the T - or B - cellular 
immunity with subsequent autoimmune response to 
certain cutaneous tissues, in the framework of so-
called Antigen Mimicry [5][12]. And while generation of 
antibodies in pemphigus subtypes could be as a 
response to different infectious antigens by antigen 
mimicry and subsequent epitope spreading, the 
screening for underlying bacterial or viral trigger and 
its subsequent elimination are as many essential 
preconditions for achieving of a clinical remission or 
satisfactory therapeutic response, as discontinuation 
of eventual drug - inductor [5, 12]. If both mechanisms 
could be implicated in the etiopathogenesis, the 
careful history and adequate screening for underlying 
infectious trigger should be the first step when dealing 
with pemphigus. Furthermore, it turns out that 
although the diagnosis of pemphigus in regular cases 
is usually not a challenge, the treatment occasionally 
could be, just because of simple pit falls in anamnesis, 
as in the presented case. The rapidly obtained and 
uncompleted history for accompanied medication 
leads to general mistakes in the subsequent treatment 
approach, as the first step in such cases is 
discontinuation of the drug-inductor. The absence of 
this information guaranties the fail of the treatment. 
On the other hand, the lack of performed screening for 
chronic or acute hepatitis and tuberculosis is not the 
only mistake, regarding the high dosage of 
immunosuppressors that have been planned as 
regiment and the possible fatal effect on their spread 
or exacerbation, but also because of the possible 
triggering ability of chronic or acute infection, which 
may play a key role in molecular mimicry, as a 
potential source of antibodies reactive with various 
tissue antigens [5]. Our patient achieved significant 
clinical resolution of the symptoms, soon after the 
discontinuation of the medication with captopril, a very 
simple step which can provide rapid and 
uncomplicated treatment and should be considered in 
earlier stages of the disease.  
With the presented case, we want to 
emphasize the importance of thorough medical 
history, in which simply pit falls may vitiate the 
treatment outcome and prognosis, but also the 
mandatory need of performance of screening for 
acute and chronic infection, prior the introduction of 
high dosage systemic immunosuppressors, including 
quantiferon test for tuberculosis and hepatitis 
serology, as a potential source of antigen/molecular 
mimicry, which is capable to produce antigens, 
complicating the pathogenesis of otherwise drug-
induced pemphigus of various type. 
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